Determinants of public and private insurance enrollment among Medicaid-eligible children

A J Davidoff1, B Garrett

  • 1Urban Institute, Washington, DC 20037, USA. adavidof@ui.urban.org

Medical Care
|June 19, 2001
PubMed

Insights

Community health centers boost Medicaid enrollment for eligible children. Employer-sponsored insurance (ESI) availability and cost significantly impact private insurance coverage for these children.

Area of Science:

  • Health Services Research
  • Health Economics
  • Public Health Policy

Background:

  • Many children eligible for Medicaid remain uninsured.
  • Understanding barriers to Medicaid participation is crucial for improving child insurance coverage.

Purpose of the Study:

  • To investigate if free/low-cost medical services substitute for Medicaid or private insurance.
  • To examine the impact of employer-sponsored insurance (ESI) and managed care on child insurance enrollment.

Main Methods:

  • Utilized National Health Interview Survey data (1994-1995).
  • Employed a multinomial choice model for Medicaid-eligible children.
  • Incorporated county-level data on provider supply (public hospitals, C/MHCs) and ESI availability/cost.

Main Results:

  • Community/migrant health center (C/MHC) supply positively influenced Medicaid enrollment.
  • No evidence of substitution between low-cost providers and public/private insurance.
  • Local ESI availability and health maintenance organization (HMO) penetration increased private insurance enrollment.

Conclusions:

  • Community providers are vital for Medicaid outreach and enrollment.
  • ESI availability and cost are key determinants of private coverage for Medicaid-eligible children.
  • Policies promoting employer insurance offers, lower premiums, and managed care can enhance coverage.
Abstract

Related Concept Videos

Introduction To Health Care Delivery System01:18

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Dimensions of Health and Illness01:21

Dimensions of Health and Illness

The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...